Clinical Trials Directory

Trials / Sponsors / Sucampo Pharma Americas, LLC

Sucampo Pharma Americas, LLC

Industry · 17 registered clinical trials.

StatusTrialPhaseStarted
CompletedEvaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo
Chronic Idiopathic Constipation
Phase 32017-03-13
CompletedComparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers
Healthy Volunteers
Phase 32016-11-16
CompletedEvaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functiona
Constipation - Functional
Phase 32016-04-12
TerminatedCobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent R
Oral Mucositis
Phase 22015-06-01
TerminatedEvaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndr
Irritable Bowel Syndrome
Phase 22015-02-01
CompletedLubiprostone for Children With Constipation
Constipation - Functional
Phase 32014-02-26
CompletedLubiprostone in Children With Functional Constipation
Constipation - Functional
Phase 32013-12-13
CompletedA Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macu
Dry Age-related Macular Degeneration
Phase 22011-05-01
CompletedOpioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)
Opioid-induced Bowel Dysfunction
Phase 32010-12-01
TerminatedEfficacy and Safety of Cobiprostone in Patients With Portal Hypertension
Portal Hypertension
Phase 22008-07-01
CompletedOpioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
Opioid-Induced Bowel Dysfunction
Phase 32007-12-01
CompletedOpioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
Opioid-Induced Bowel Dysfunction
Phase 32007-08-01
CompletedCobiprostone Prevention of NSAID-induced Gastroduodenal Injury
NSAID-induced Gastroduodenal Injury, Ulcers, Rheumatoid Arthritis
Phase 22007-08-01
CompletedOpioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
Opioid-Induced Bowel Dysfunction
Phase 32007-08-01
CompletedSafety and Efficacy of Lubiprostone in Pediatric Patients With Constipation
Constipation
Phase 42007-01-01
CompletedEfficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
Irritable Bowel Syndrome, Constipation
Phase 32005-05-01
CompletedEfficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
Irritable Bowel Syndrome With Constipation
Phase 32005-05-01